Evaluation of Virtual Reality to Reduce Anxiety, Pain and Duration of Non-emergency Vigile Bronchial Fibroscopy (AVATAR)

Recruiting now · Not applicable

Conditions studied: Respiratory Disorder, Lung Infection

In brief

Bronchial fibroscopy (BF) is a routine practice examination in critical care areas. It can be useful either for the diagnosis of the causal pathology of respiratory distress or for the diagnosis of lung infection, sometimes nosocomial. In patients in spontaneous and conscious ventilation, BF are performed vigil after local anesthesia according to the recommendations of the Société de Pneumologie de langue Française. The good tolerance of the examination and its good conduct may require the use of anxiolytics, sedatives or analgesics to limit the traumatic experience of a highly anxiety-provoking examination. Virtual reality (VR) combines a set of paramedical techniques (hypnosis, music therapy, sophrology) and is now a non-drug alternative to improve the tolerance of certain invasive gestures.VR has been shown to reduce pain and anxiety during first pathways placement or digestive endoscopies. To date, there is no evidence of the benefit of VR when performing semi-urgent BF in critical care areas.

Key facts

Study ID

NCT05973201

Run by

Assistance Publique - Hôpitaux de Paris

People needed

120

Starts

2023-10-19

Expected to finish

2025-10-26

Last updated by the study team

2024-12-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults (over 18 years of age)
• Hospitalized in a critical care unit (intensive care and intensive care)
• Conscious (Glasgow score >13)
• Spontaneous ventilation
• Requiring the realization of a FB
• First BF during hospitalization
• Having signed a consent to participate in the study
• Affiliation to social security

You may not qualify if…

• Non-French-speaking patient
• Protected minors or adults who cannot consent to participate
• People with major neurocognitive impairment
• Patient refusing to participate in the study
• Patient on State medical aid
• Patient under guardianship or curatorship or under judicial protection
• BF for a vital emergency
• Prior inclusion in the study
• Pregnant or breastfeeding women
• Presence of a tracheostomy or tracheostomy
• Participation in other intervention research
• Epilepsy
• Visual impairment (blindness) or severe hearing impairment (hearing loss, deafness) that does not allow the use of the helmet
• Psychiatric pathologies such as delusional disorders, hallucinations or schizophrenia.
• Autism spectrum disorders
• Patient sensitive to motion sickness
• Refractory migraine under treatment

Where it is running

• CHI Aix en Provence — Aix-en-Provence, France (enrolling)
• CHU Dijon — Dijon, France (enrolling)
• Hôpital européen Georges Pompidou - AP-HP — Paris, France (enrolling)
• Hôpital Le Kremlin Bicêtre — Le Kremlin-Bicêtre, France
• Hôpital Foch — Suresnes, France

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.